BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lian MJ, Zhang JQ, Chen SD, Zhang DD, Yang YY, Hong GL. Diagnostic accuracy of γ-glutamyl transpeptidase-to-platelet ratio for predicting hepatitis B-related fibrosis: a meta-analysis. Eur J Gastroenterol Hepatol 2019;31:599-606. [PMID: 30807447 DOI: 10.1097/MEG.0000000000001381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ha Y, Chon YE, Kim MN, Lee JH, Hwang SG. Gamma-Glutamyl Transpeptidase Dynamics as a Biomarker for Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease. J Gastroenterol Hepatol 2022. [PMID: 35467042 DOI: 10.1111/jgh.15871] [Reference Citation Analysis]
2 Yu Y, Cui X, Zhao J, Jia T, Ren B, Zhang X. Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF-α and IL-6 Levels in Patients with Hepatitis B Cirrhosis. J Oncol 2021;2021:9162346. [PMID: 34484339 DOI: 10.1155/2021/9162346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ekin N, Ucmak F, Ebik B, Tugba Tuncel E, Kacmaz H, Arpa M, Engin Atay A. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients. Acta Gastroenterol Belg 2022;85:62-8. [PMID: 35304995 DOI: 10.51821/85.1.9156] [Reference Citation Analysis]
4 Yang Z, Ma X, Zhou X, Huang D, Wang Y, Li X, Lu W, Zhang Z, Ding R. Predictive performance of eLIFT for liver inflammation and fibrosis in chronic liver diseases. Int J Med Sci 2021;18:3599-608. [PMID: 34522187 DOI: 10.7150/ijms.62386] [Reference Citation Analysis]
5 Wu J, Mao W. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases. Dis Markers 2020;2020:2471252. [PMID: 32774512 DOI: 10.1155/2020/2471252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]